Skip to content

Expiring federal contract

75N93023P00594 — Dna Twopointo INC.

Department of Health and Human Services · National Institutes of Health

Contract / PIID
75N93023P00594
Incumbent
Dna Twopointo INC.
Incumbent UEI
G9S3SC8T5DM1
Current end date
May 13, 2027
Potential total value
$300,000
Obligated
$300,000
NAICS
325414 — Biological Product (except Diagnostic) Manufacturing
PSC
6505 — DRUGS AND BIOLOGICALS
Set-aside
Full & Open
Start date
May 14, 2023
Place of performance
CA
Award type
PURCHASE ORDER

Source: USASpending.gov award record, last checked November 18, 2026. Place of performance as reported by USASpending.

What the contract covers

YEARLY LICENSE (MAINTENANCE FEE AND IND FILING FEE) TO USE A MONOCLONAL ANTIBODY PRODUCED VIA ATUM PROPRIETARY CELL LINE TECHNOLOGY

Likely rebid window (estimate)

  • Sources Sought / RFI: about May 2026 – Nov 2026 (6–12 months before the end date)
  • RFP: about Jan 2027 – Mar 2027 (2–4 months before the end date)

Between the estimated Sources Sought and RFP windows.

Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.

Track this recompete free

  • Change history: no changes recorded since Mindy began tracking this contract.
  • Alerts: get an email when the end date moves or the follow-on is posted.
  • Contacts: the buying office and small-business contacts for this agency.

Other contracts expiring at Department of Health and Human Services (NAICS 325414)